All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.

Delve into Recursion's unique TechBio approach. Discover how we're revolutionizing AI drug discovery and the biotech industry. Read more about our approach today!

Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high unmet need, …

Oct 9, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, …

By leveraging Recursion’s vast data universe and machine learning models at every stage of the discovery, design and delivery process, we are able to rapidly validate and accelerate high-potential …

Oct 21, 2024 · Recursion is a leading techbio company decoding biology to radically improve lives. By leveraging advanced technologies and massive datasets, Recursion aims to build a next-generation …

Access real-time stock information and charts for Recursion Pharmaceuticals, Inc., providing insights into the company's financial performance and market trends.

Within Recursion, this process typically requires biologists to delineate biological pathways and establish novel map relationships, followed by chemists optimizing chemical series for the selected targets.

Jun 6, 2025 · Powered by Recursion's NVIDIA supercomputer for its training and validation, this next-generation AI model achieves best-in-class accuracy in jointly modeling complex structures and …

Feb 25, 2026 · Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and …